The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Amyloid beta protein levels in cerebrospinal fluid are elevated in early-onset Alzheimer's disease.
Department of Neurology, Gunma University School of Medicine, Japan.
Annals of neurology 1994;36(6):903-11.
The 4-kd amyloid beta protein (A beta) deposited as amyloid in Alzheimer's disease (AD) is produced and released by normal proteolytic processing of the amyloid beta protein precursor (beta APP) and is readily detected in cerebrospinal fluid (CSF). Here, we present the levels of A beta in CSF from a total of 95 subjects, including 38 patients with AD, 14 with early-onset AD and 24 with late-onset AD, 25 normal control subjects, and 32 patients with other neurological diseases. The level of A beta decreased with normal aging, and there was a significant elevation in the level of A beta in the CSF of early-onset AD patients (4.14 +/- 1.37 pmol/ml, p < 0.01). Neither Mini-Mental State nor Functional Assessment Staging were correlated with the amount of A beta in the CSF. The A beta/secreted form of beta APP ratio was elevated, but the level of alpha 1-antichymotrypsin in the CSF did not correlate with the level of CSF A beta in early-onset AD patients. Thus, the level of A beta in the CSF is elevated in early-onset AD patients and is suggested to be correlated with the pathology in the brain that characterizes AD.
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
TANZI, RUDOLPH EMILE
30 September 2012 - 31 August 2017
NATIONAL INSTITUTE ON AGING
Total Funding: $ 345,936
SISODIA, SANGRAM S.
1 September 2011 - 30 June 2016
NATIONAL INSTITUTE ON AGING
Total Funding: $ 391,536
KOO, EDWARD H
1 May 1996 - 30 April 2001
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
Total Funding: $ 330,509
K Kanemaru; Y IharaTanpakushitsu kakusan koso. Protein, nucleic acid, enzyme 1991;36(1):2-11.
L M Bekris; N M Galloway; S Millard; D Lockhart; G Li; D R Galasko; M R Farlow; C M Clark; J F Quinn; J A Kaye; et al.Neurobiology of aging 2011;32(3):556.e13-23.
L Mucke; G Q Yu; L McConlogue; E M Rockenstein; C R Abraham; E MasliahThe American journal of pathology 2000;157(6):2003-10.
Appears in this Publication
Author of this Publication